Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

N9+

K-Number: K223785 · 2023-04-14

Decision Date2023-04-14
Product CodeDQD
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

N9+ is the device name listed in this FDA 510(k) record. The listed applicant is Nonagon , Ltd.. It received FDA 510(k) clearance on 2023-04-14 under 510(k) number K223785. The device is classified under product code DQD. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the N9+?

N9+ is a medical device that received FDA 510(k) clearance on 2023-04-14. The listed applicant is Nonagon , Ltd.. The 510(k) number is K223785.

When did N9+ receive FDA 510(k) clearance?

N9+ received FDA 510(k) clearance on 2023-04-14, under 510(k) number K223785.

Who is the listed applicant for N9+?

The FDA 510(k) record lists Nonagon , Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for N9+?

The FDA product code for N9+ is DQD.

Related Devices (Code: DQD)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.